Immunotherapy-related interstitial lung disease: a call to improve risk stratification and diagnostic consistency.

Fabbri L, Antoniou K, Blum TG, Camus P, Cazes A, Chorostowska-Wynimko J, Foidart P, Hardavella G, Heuvelmans MA, Karampitsakos T, Kreuter M, Pereira Catarata MJ, Naidoo J, Passaro A, Peters S, Prosch H, Russell AM, Tarnoki DL, Porter JC, Guiot J

Open source

DOI
10.1183/23120541.01586-2025
Published
2026 May
Container
ERJ open research
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1183/23120541.01586-2025,
  title = {Immunotherapy-related interstitial lung disease: a call to improve risk stratification and diagnostic consistency.},
  author = {Fabbri L and Antoniou K and Blum TG and Camus P and Cazes A and Chorostowska-Wynimko J and Foidart P and Hardavella G and Heuvelmans MA and Karampitsakos T and Kreuter M and Pereira Catarata MJ and Naidoo J and Passaro A and Peters S and Prosch H and Russell AM and Tarnoki DL and Porter JC and Guiot J},
  year = {2026},
  journal = {ERJ open research},
  doi = {10.1183/23120541.01586-2025},
  url = {https://doi.org/10.1183/23120541.01586-2025}
}

RIS

TY  - JOUR
TI  - Immunotherapy-related interstitial lung disease: a call to improve risk stratification and diagnostic consistency.
AU  - Fabbri L
AU  - Antoniou K
AU  - Blum TG
AU  - Camus P
AU  - Cazes A
AU  - Chorostowska-Wynimko J
AU  - Foidart P
AU  - Hardavella G
AU  - Heuvelmans MA
AU  - Karampitsakos T
AU  - Kreuter M
AU  - Pereira Catarata MJ
AU  - Naidoo J
AU  - Passaro A
AU  - Peters S
AU  - Prosch H
AU  - Russell AM
AU  - Tarnoki DL
AU  - Porter JC
AU  - Guiot J
PY  - 2026
JO  - ERJ open research
DO  - 10.1183/23120541.01586-2025
UR  - https://doi.org/10.1183/23120541.01586-2025
ER  - 

APA

L, F., K, A., TG, B., P, C., A, C., J, C., P, F., G, H., MA, H., T, K., M, K., MJ, P. C., J, N., A, P., S, P., H, P., AM, R., DL, T., JC, P., & J, G. (2026). Immunotherapy-related interstitial lung disease: a call to improve risk stratification and diagnostic consistency.. ERJ open research. https://doi.org/10.1183/23120541.01586-2025

Source records